Literature DB >> 7946756

Symptoms and quality of life in heart failure: the muscle hypothesis.

A J Coats1, A L Clark, M Piepoli, M Volterrani, P A Poole-Wilson.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7946756      PMCID： PMC1025572          DOI： 10.1136/hrt.72.2_suppl.s36

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  25 in total

Review 1.  Evaluation of quality of life in clinical trials of cardiovascular disease.

Authors:  A E Fletcher; B M Hunt; C J Bulpitt
Journal:  J Chronic Dis       Date:  1987

2.  Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantation.

Authors:  L I Sinoway; J R Minotti; D Davis; J L Pennock; J E Burg; T I Musch; R Zelis
Journal:  Am J Cardiol       Date:  1988-05-01       Impact factor: 2.778

Review 3.  Dyspnoea: assessment and pharmacological manipulation.

Authors:  R D Stark
Journal:  Eur Respir J       Date:  1988-03       Impact factor: 16.671

4.  Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure.

Authors:  A R Feinstein; M B Fisher; J G Pigeon
Journal:  Am J Cardiol       Date:  1989-07-01       Impact factor: 2.778

5.  Subnormal heart period variability in heart failure: effect of cardiac transplantation.

Authors:  M L Smith; K A Ellenbogen; D L Eckberg; S Szentpetery; M D Thames
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

6.  Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.

Authors:  B Massie; M Conway; R Yonge; S Frostick; J Ledingham; P Sleight; G Radda; B Rajagopalan
Journal:  Circulation       Date:  1987-11       Impact factor: 29.690

7.  Factors determining symptoms in heart failure: comparison of fast and slow exercise tests.

Authors:  D P Lipkin; R Canepa-Anson; M R Stephens; P A Poole-Wilson
Journal:  Br Heart J       Date:  1986-05

8.  Abnormalities of skeletal muscle in patients with chronic heart failure.

Authors:  D P Lipkin; D A Jones; J M Round; P A Poole-Wilson
Journal:  Int J Cardiol       Date:  1988-02       Impact factor: 4.164

9.  Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

Authors:  H Drexler; U Banhardt; T Meinertz; H Wollschläger; M Lehmann; H Just
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

10.  Vasodilatory behavior of skeletal muscle arterioles in patients with nonedematous chronic heart failure.

Authors:  J R Wilson; D H Wiener; L I Fink; N Ferraro
Journal:  Circulation       Date:  1986-10       Impact factor: 29.690
View more
  74 in total

1.  Case report: exercise in a patient with acute decompensated heart failure receiving positive inotropic therapy.

Authors:  Ricard Paul E H; Robert Camarda; Laura Little Foley; Michael M Givertz; Lawrence P Cahalin
Journal:  Cardiopulm Phys Ther J       Date:  2011-06

Review 2.  Testosterone and heart failure.

Authors:  Maurizio Volterrani; Giuseppe Rosano; Ferdinando Iellamo
Journal:  Endocrine       Date:  2012-06-24       Impact factor: 3.633

Review 3.  Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction.

Authors:  D Walter Wray; Markus Amann; Russell S Richardson
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 4.  Effects of exercise training on neurovascular control and skeletal myopathy in systolic heart failure.

Authors:  Carlos E Negrao; Holly R Middlekauff; Igor L Gomes-Santos; Ligia M Antunes-Correa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

Review 5.  A review of the relationship between leg power and selected chronic disease in older adults.

Authors:  S E Strollo; P Caserotti; R E Ward; N W Glynn; B H Goodpaster; E S Strotmeyer
Journal:  J Nutr Health Aging       Date:  2015-02       Impact factor: 4.075

6.  Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure.

Authors:  Ronald B Myers; Jun Yoshioka
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-13       Impact factor: 4.733

7.  Vascular KATP channels mitigate severe muscle O2 delivery-utilization mismatch during contractions in chronic heart failure rats.

Authors:  Clark T Holdsworth; Scott K Ferguson; Trenton D Colburn; Alexander J Fees; Jesse C Craig; Daniel M Hirai; David C Poole; Timothy I Musch
Journal:  Respir Physiol Neurobiol       Date:  2017-01-22       Impact factor: 1.931

Review 8.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

Review 9.  Integrated Cardio-Respiratory Control: Insight in Diabetes.

Authors:  Luciano Bernardi; Lucio Bianchi
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

10.  Comparison of skeletal muscle strength between cardiac patients and age-matched healthy controls.

Authors:  K Baum; U Hildebrandt; K Edel; R Bertram; H Hahmann; F J Bremer; S Böhmen; C Kammerlander; M Serafin; Th Rüther; E Miche
Journal:  Int J Med Sci       Date:  2009-07-06       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.